Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: Big Draws and New Stars

We’re halfway through September! Although the fall season hasn’t officially started in terms of the weather, the business world and Bullboards have certainly picked up in activity. Every week we track the most-viewed Bullboards in each ...
Omri Wallach | September 19, 2019 |

Buzz on the Bullboards: Rising Investment Opportunities

It’s been a busy week for the markets, which means a busy week for the Stockhouse Bullboards. From new sector mainstays to sudden investment opportunities, we saw a bit of everything over the last week. On our weekly Buzz on the Bullboards review, we dive i...
Omri Wallach | September 25, 2019 |

Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody

Curis Inc. shares are up more than 130% and established a new 52-week high price after reporting that the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody. Biotechnology company Curis Inc. (CRIS:NASDAQ) , which concentrates...
Streetwise Reports | June 11, 2020 |

East-West Trade War: Never Take a Knife to a Gunfight

It's a funny thing that happens when the stress of financial insolvency bubbles up to the surface. Decisions once considered "routine" (like brushing one's teeth or walking one's dog) suddenly have life-or-death outcomes, complete with cold sweats, sleepless nights and ...
Streetwise Reports | October 11, 2019 |

Frank Holmes: Gold Is Going to $10,000

The Gold Report: Frank, you've said you expect gold to reach $10,000/oz. Can you tell us about your prediction and the factors that you see behind it? Frank Holmes: When you look at the world of gold and at negative real interest rates, it is unprecedented that in...
Streetwise Reports | October 23, 2019 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

ACADIA Pharma's Shares Open 75% Higher on Positive Anti-Psychosis Drug Phase 3 Results

Shares of ACADIA Pharmaceuticals opened up 75% higher today after the company announced that its Phase 3 Study of pimavanserin for the treatment of dementia-related psychosis met its primary endpoint. San Diego, Calif.-based biopharmaceutical company ACADIA Pharmaceu...
Streetwise Reports | September 10, 2019 |

Copper noose tightening

Copper prices surged to a one-month high on Monday, on potential supply disruptions owing to violent protests in Chile over a proposed law, now suspended, that would raise the prices of transit tickets. At least 11 people have died, according to the mayor of Sant...
Richard (Rick) Mills | October 23, 2019 |

Cash Balances Could Push Stock Market Much Higher

HIGHEST IN A DECADE According to Lipper and The Wall Street Journal , money market balances were basically identical on October 30, 2019 and March 25, 2009. It is easy to understand how money market balances reached extremely high levels in March 2...
Chris Ciovacco | November 20, 2019 |

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...
Streetwise Reports | May 21, 2020 |
1 2 3 4 5 6 7 8 9 10 ...